Oxycodon/Naloxon Hexal (Naloxone Hydrochloride Dihydrate, Oxycodone Hydrochloride Ph. Eur.)

Oxycodon/Naloxon Hexal is used in the context of opioid‑based pain management for several clinical situations:

• Chronic non‑cancer pain: provides sustained analgesia while reducing abuse potential.
• Cancer‑related pain: offers strong opioid relief for breakthrough and background pain.
• Post‑operative pain: delivers effective short‑term control after major surgery.
• Severe acute pain episodes: manages intense pain episodes where rapid onset is required.

• The formulation combines oxycodone, a µ‑opioid receptor agonist that mimics endogenous opioids to inhibit pain transmission in the central nervous system, with naloxone, a peripheral µ‑opioid receptor antagonist that remains inactive when taken orally but blocks opioid effects if the product is injected, thereby reducing the risk of opioid‑induced respiratory depression and misuse.

Adverse reactions may occur with Oxycodon/Naloxon Hexal and should be monitored during therapy.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel movements.
• Dizziness: light‑headed sensation.
• Somnolence: increased sleepiness.
• Dry mouth: reduced salivation.
• Headache: mild cranial pain.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing, potentially life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Hepatic impairment: liver function abnormalities.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Opioid dependence or withdrawal: signs of addiction or withdrawal syndrome.
• Seizures: rare convulsive events.

When prescribing Oxycodon/Naloxon Hexal, clinicians should consider several safety aspects:

• Assess pain severity: confirm that opioid therapy is appropriate for the patient’s level of pain.
• Review medical history: evaluate for respiratory disorders, liver disease, or prior substance misuse.
• Monitor for sedation: watch for excessive drowsiness or impaired cognition.
• Avoid concurrent CNS depressants: limit use of alcohol, benzodiazepines, or other sedatives.
• Educate patients: inform about proper oral use and risks of injection.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodon/Naloxon Hexal can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression.
• MAO inhibitors: increase risk of serotonin syndrome and hypertensive crisis.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): elevate oxy‑oxycodone plasma levels.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce oxycodone metabolism.
• Diuretics: can enhance hypotensive effects.
• Anticholinergics: may worsen constipation.
• Antihistamines: increase sedation risk.
• Herbal supplements (e.g., St John’s wort): may alter opioid metabolism.